Market News Archives

AT&T’s $23 Billion EchoStar Spectrum Deal: What It Means for 5G, Broadband, and U.S. Wireless Competition – ( $SATS $T )

by John F. Heerdink, Jr. August 27, 2025 625Views 0Likes

AT&T (T) struck a $23 billion deal this week to acquire wireless spectrum licenses from EchoStar(SATS), a move set to significantly bolster its holdings across more than 400 U.S. markets and intensify the telecom arms race nationwide. The all-cash transaction, announced Tuesday,…

Production Milestone Further Positions Modular Medical for U.S. and EU Growth – ( $MODD $LLY $MDT $PODD )

by John F. Heerdink, Jr. August 26, 2025 498Views 0Likes

Modular Medical (NASDAQ: MODD) has announced a series of transformative developments positioning the company at the forefront of diabetes technology innovation. Robust Manufacturing Momentum In August, Modular Medical completed a pivotal production milestone, finalizing over 6,000 MODD1 cartridges and seamlessly transitioning manufacturing…

Serina Therapeutics Gains FDA ‘Green Light’: Seeking to Accelerate Parkinson’s Innovation with POZ Platform – ( $SER $BMY )

by John F. Heerdink, Jr. August 25, 2025 725Views 0Likes

Serina Therapeutics (NYSE American: SER) is rapidly emerging as a compelling force in biotechnology, innovating at the intersection of neuroscience, advanced drug delivery, and capital efficiency—a combination that has resonated with investors and is gaining Wall Street momentum. The latest, game-changing press…

Reinventing Diabetes Care: Modular Medical’s Bold Bet on Simpler, Smarter Insulin Delivery – ( $MODD )

by John F. Heerdink, Jr. August 7, 2025 584Views 0Likes

Modular Medical (NASDAQ: MODD), a potential disruptor in diabetes care technology, is rapidly moving from visionary concept to tangible innovation as it propels its FDA cleared MODD1 insulin patch pump toward commercial launch. The company has recently validated its MODD1 cartridge manufacturing…

U.S.-Based GeoVax Emerges as Key Monopoly Challenger Amid $2.99B Bavarian Nordic Takeover – ($GOVX $IBB $XBI)

by John F. Heerdink, Jr. July 31, 2025 519Views 0Likes

Bavarian Nordic, a leading Danish vaccine manufacturer best known for its MVA-BN (Modified Vaccinia Ankara–Bavarian Nordic) smallpox and mpox vaccines, recently agreed to a $2.99 billion takeover by private equity firms Permira and Nordic Capital. Shareholders are being offered 233 Danish kroner…

Merck Sets Its Sights on Eyebiotech: Pharma Giant Eyes $1.3 Billion Move Into Vision Care

by John F. Heerdink, Jr. July 11, 2025 413Views 0Likes

Merck (MRK) is setting its sights on a new frontier—your eyes. The pharmaceutical heavyweight is on the verge of acquiring Eyebiotech, an ophthalmology biotech upstart, in a deal valued at a crisp $1.3 billion. If finalized, this move would mark Merck’s debut into the…

Eupraxia Advances EoE Drug Development With Phase 2b Milestone – ( $EPRX $IBB $XBI )

by John F. Heerdink, Jr. July 9, 2025 666Views 0Likes

Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX, TSX: EPRX) has taken a significant step in its quest to address one of gastroenterology’s most stubborn challenges: eosinophilic esophagitis (EoE). The Victoria, Canada-based biotechnology firm announced (July 8, 2025) that it has dosed the first patient in…

Serina Therapeutics: Optimizing Drug Delivery for the Future – ( $SER )

by John F. Heerdink, Jr. July 7, 2025 461Views 0Likes

Serina Therapeutics (NYSE: SER) is positioning itself at the forefront of a new era in drug development, as highlighted in a recent corporate video titled "Rethinking Drug Development: Faster, Smarter, Strategic and reinforced by a series of strategic moves and partnerships.…

From Bitcoin to Ethereum: BitMine’s Bold Treasury Move Draws Wall Street’s Attention ( $BMNR $BTC $ETH )

by John F. Heerdink, Jr. July 1, 2025 445Views 0Likes

BitMine Immersion Technologies (Nasdaq: BMNR), a Las Vegas-based cryptocurrency miner, has dramatically repositioned itself with a bold pivot toward Ethereum, igniting a spectacular surge in its stock price. On June 30, the company announced a $250 million private placement aimed at building…

Modular Medical (Nasdaq: MODD) Unveils Updated Investor Presentation, Emphasizing Disruptive Business Model and Near-Term Milestones

by John F. Heerdink, Jr. June 30, 2025 729Views 0Likes

Over the weekend, Modular Medical, Inc. (Nasdaq: MODD), a San Diego-based innovator in insulin delivery technology, quietly published an updated investor presentation , signaling a new phase in its campaign to transform diabetes care. The release comes on the heels of the…

Market News

Your Guide To Staying Informed In The Markets